Drug Shortage Report for MYLAN-IPRATROPIUM SOLUTION
Report ID | 30371 |
Drug Identification Number | 02239131 |
Brand name | MYLAN-IPRATROPIUM SOLUTION |
Common or Proper name | IPRATROPIUM SOLUTION |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | IPRATROPIUM BROMIDE |
Strength(s) | 0.25MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION |
Packaging size | 20ML |
ATC code | R03BB |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-02 |
Actual start date | 2018-07-03 |
Estimated end date | Unknown |
Actual end date | 2018-07-03 |
Shortage status | Resolved |
Updated date | 2018-07-05 |
Company comments | Discontinued in ID 30368 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-07-05 | French | Compare |
v9 | 2018-07-05 | English | Compare |
v8 | 2018-07-04 | English | Compare |
v7 | 2018-07-03 | French | Compare |
v6 | 2018-07-03 | English | Compare |
v5 | 2018-07-03 | French | Compare |
v4 | 2018-07-03 | English | Compare |
v3 | 2018-07-03 | English | Compare |
v2 | 2017-11-23 | French | Compare |
v1 | 2017-11-23 | English | Compare |
Showing 1 to 10 of 10